Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

NCT01289080 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Psychiatric Disorders

Interventions

DRUG: OPC-34712

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.